Literature DB >> 8627349

Reinduction of hyponatremia improves survival in rats with myelinolysis-related neurologic symptoms.

A Soupart1, R Penninckx, A Stenuit, O Perier, G Decaux.   

Abstract

Brain myelinolysis occurs after excessive correction (delta SNa > 20 mEq/1/24 hours) of chronic hyponatremia. However, we showed recently that the mechanisms leading to brain myelinolysis remain reversible. Indeed, reinduction of the hyponatremia by water administration despite 12 hours of sustained excessive correction could prevent the development of demyelination in rats still asymptomatic at that time. Whether this therapeutic maneuver could be also beneficial to rats with preexisting myelinolysis-related neurologic symptoms is unknown. Therefore we evaluated here the effect of reinduction of the hyponatremia on the survival and on brain damage in rats presenting obvious neurologic symptoms after excessive correction of hyponatremia. After 3 days of severe hyponatremia induced by 2.5 D-glucose in water and continuous infusion of AVP, rats were submitted to a large correction (delta SNa approximately 30 mEq/l) by 2 i.p. injections of hypertonic saline given over 24 hours. In group I (n = 15) the rats developing neurologic symptoms during the first 24 hours of correction received one i.p. injection of distilled water which rapidly decreased the natremia to a final correction gradient <20 mEq/l/24 hour. In group II (n = 13, controls) the symptomatic rats were left permanently overcorrected. In group I, after water administration, the neurological manifestations were generally attenuated or disappeared. Seven of the 15 rats (47%) in this group survived up to day 10 with a mean survival time of 7.5 +/- 2 days, an outcome clearly improved as compared to group II (controls): only 1 of the 13 rats (7%, p < 0.03) was still alive on day 10 and the mean survival time was 3.3 +/- 2 days (p < 0.001) in this group II. The duration of the symptoms also influences the prognosis. In group I, in 9 rats the water administration was performed 4 hours after symptoms onset. These rats had a better outcome than the 6 rats with more sustained (8-10 hours) neurologic symptoms before water loading. Brain analysis in the 7 surviving rats of group I demonstrated demyelinating lesions in only 2 of them, suggesting the reversibility of the process even when neurologic manifestation developed. In conclusion, after exposure to an excessive correction of chronic hyponatremia, even when rats have developed myelinolysis-related neurologic symptoms, hypotonic fluids administration could improve survival and could prevent the subsequent development of brain myelinolysis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8627349     DOI: 10.1097/00005072-199605000-00011

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  17 in total

1.  Treatment of the osmotic demyelination syndrome: the earlier the better?

Authors:  Mohamed Osama Hegazi
Journal:  Intern Emerg Med       Date:  2016-10-18       Impact factor: 3.397

2.  Minocycline protects against neurologic complications of rapid correction of hyponatremia.

Authors:  Fabrice Gankam-Kengne; Alain Soupart; Roland Pochet; Jean Pierre Brion; Guy Decaux
Journal:  J Am Soc Nephrol       Date:  2010-11-04       Impact factor: 10.121

Review 3.  Therapeutic Relowering of Plasma Sodium after Overly Rapid Correction of Hyponatremia: What Is the Evidence?

Authors:  Helbert Rondon-Berrios
Journal:  Clin J Am Soc Nephrol       Date:  2019-10-10       Impact factor: 8.237

4.  Alterations in glial cell metabolism during recovery from chronic osmotic stress.

Authors:  U Flögel; D Leibfritz
Journal:  Neurochem Res       Date:  1998-12       Impact factor: 3.996

5.  The therapeutic effect of hypertonic solutions on the changes in the effective circulating plasma volume in acute necrotizing pancreatitis in rats.

Authors:  Y Kondo; H Nagai; K Kasahara; K Kanazawa
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

6.  DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia.

Authors:  Anjana Perianayagam; Richard H Sterns; Stephen M Silver; Marvin Grieff; Robert Mayo; John Hix; Ruth Kouides
Journal:  Clin J Am Soc Nephrol       Date:  2008-01-30       Impact factor: 8.237

7.  Extrapontine myelinolysis caused by rapid correction of pituitrin-induced severe hyponatremia: A case report.

Authors:  Liang-Jie Fang; Ming-Wei Xu; Jian-Ying Zhou; Zhi-Jie Pan
Journal:  World J Clin Cases       Date:  2020-03-06       Impact factor: 1.337

Review 8.  Hyponatremia in the Neurologically Ill Patient: A Review.

Authors:  David P Lerner; Starane A Shepherd; Ayush Batra
Journal:  Neurohospitalist       Date:  2020-01-10

9.  Treatment of euvolemic hyponatremia in the intensive care unit by urea.

Authors:  Guy Decaux; Caroline Andres; Fabrice Gankam Kengne; Alain Soupart
Journal:  Crit Care       Date:  2010-10-14       Impact factor: 9.097

10.  Actual Therapeutic Indication of an Old Drug: Urea for Treatment of Severely Symptomatic and Mild Chronic Hyponatremia Related to SIADH.

Authors:  Guy Decaux; Fabrice Gankam Kengne; Bruno Couturier; Frédéric Vandergheynst; Wim Musch; Alain Soupart
Journal:  J Clin Med       Date:  2014-09-18       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.